275 related articles for article (PubMed ID: 28516725)
21. Safety of Recombinant Zoster Vaccine in Patients with Inflammatory Bowel Disease.
Satyam VR; Li PH; Reich J; Qazi T; Noronha A; Wasan SK; Farraye FA
Dig Dis Sci; 2020 Oct; 65(10):2986-2991. PubMed ID: 31897892
[TBL] [Abstract][Full Text] [Related]
22. Risk of Disseminated Varicella Zoster in Immunosuppressed Patients Receiving Zoster Vaccination.
Bubb MR
Mayo Clin Proc; 2015 Nov; 90(11):1585-6. PubMed ID: 26541254
[No Abstract] [Full Text] [Related]
23. Increased risk of varicella zoster virus infection in inflammatory bowel disease in an Asian population: a nationwide population-based cohort study.
Tsai SY; Yang TY; Lin CL; Tsai YH; Kuo CF; Kao CH
Int J Clin Pract; 2015 Feb; 69(2):228-34. PubMed ID: 25363271
[TBL] [Abstract][Full Text] [Related]
24. In reply--Risk of Disseminated Varicella Zoster in Immunosuppressed Patients Receiving Zoster Vaccination.
Cheetham TC; Sy LS; Jacobsen SJ
Mayo Clin Proc; 2015 Nov; 90(11):1586-7. PubMed ID: 26541255
[No Abstract] [Full Text] [Related]
25. Safety of inadvertent administration of live zoster vaccine to immunosuppressed individuals in a UK-based observational cohort analysis.
Grint DJ; McDonald HI; Walker JL; Amirthalingam G; Andrews N; Thomas S
BMJ Open; 2020 Jan; 10(1):e034886. PubMed ID: 32001495
[TBL] [Abstract][Full Text] [Related]
26. Incidence and Prevention of Herpes Zoster Reactivation in Patients with Autoimmune Diseases.
Chakravarty EF
Rheum Dis Clin North Am; 2017 Feb; 43(1):111-121. PubMed ID: 27890168
[TBL] [Abstract][Full Text] [Related]
27. Herpes zoster: diagnostic, therapeutic, and preventive approaches.
Bader MS
Postgrad Med; 2013 Sep; 125(5):78-91. PubMed ID: 24113666
[TBL] [Abstract][Full Text] [Related]
28. Differential uptake of herpes zoster vaccination associated with socioeconomic status: A population-based study in Stockholm County, Sweden.
Fogelberg S; Lamb F; Grönlund O; Eriksson I; Sundström K; Clements M; Arnheim-Dahlström L
Pharmacoepidemiol Drug Saf; 2018 Nov; 27(11):1159-1165. PubMed ID: 30221421
[TBL] [Abstract][Full Text] [Related]
29. Incidence and risk factors for herpes zoster among patients with inflammatory bowel disease.
Gupta G; Lautenbach E; Lewis JD
Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1483-90. PubMed ID: 17162240
[TBL] [Abstract][Full Text] [Related]
30. Varicella-zoster-virus vaccination of immunosuppressed children with inflammatory bowel disease or autoimmune hepatitis: A prospective observational study.
Seitel T; Cagol L; Prelog M; Frivolt K; Krahl A; Trenkel S; Speth F; Mayer B; Almanzar G; Koletzko S; Debatin KM; Mertens T; Posovszky C
Vaccine; 2020 Nov; 38(50):8024-8031. PubMed ID: 33160754
[TBL] [Abstract][Full Text] [Related]
31. Increased risk of herpes zoster infection in patients with inflammatory bowel disease: a meta-analysis of cohort studies.
Ning L; Liu R; Li S; Shan G; Du H; Zhang J; Chen W; Zhang F; Yu J; Xu G
Eur J Clin Microbiol Infect Dis; 2020 Feb; 39(2):219-227. PubMed ID: 31650411
[TBL] [Abstract][Full Text] [Related]
32. Herpes Zoster virus infection and the risk of developing dementia: A systematic review and meta-analysis.
Elhalag RH; Motawea KR; Talat NE; Rouzan SS; Reyad SM; Elsayed SM; Chébl P; Abowafia M; Shah J
Medicine (Baltimore); 2023 Oct; 102(43):e34503. PubMed ID: 37904465
[TBL] [Abstract][Full Text] [Related]
33. Herpes Zoster Incidence in Inflammatory Bowel Disease Patients: A Population-Based Study.
Côté-Daigneault J; Bessissow T; Nicolae MV; Nie R; Bitton A; Lakatos PL; Brassard P
Inflamm Bowel Dis; 2019 Apr; 25(5):914-918. PubMed ID: 30295818
[TBL] [Abstract][Full Text] [Related]
34. Increased risk of herpes zoster among 108 604 patients with inflammatory bowel disease.
Long MD; Martin C; Sandler RS; Kappelman MD
Aliment Pharmacol Ther; 2013 Feb; 37(4):420-9. PubMed ID: 23240738
[TBL] [Abstract][Full Text] [Related]
35. Zostavax : a subcutaneous vaccine for the prevention of herpes zoster.
Doan HQ; Ung B; Ramirez-Fort MK; Khan F; Tyring SK
Expert Opin Biol Ther; 2013 Oct; 13(10):1467-77. PubMed ID: 23984934
[TBL] [Abstract][Full Text] [Related]
36. Serious infections in patients with inflammatory bowel disease receiving anti-tumor-necrosis-factor-alpha therapy: an Australian and New Zealand experience.
Lawrance IC; Radford-Smith GL; Bampton PA; Andrews JM; Tan PK; Croft A; Gearry RB; Florin TH
J Gastroenterol Hepatol; 2010 Nov; 25(11):1732-8. PubMed ID: 21039834
[TBL] [Abstract][Full Text] [Related]
37. Incidence and clinical characteristics of herpes zoster after lung transplantation.
Manuel O; Kumar D; Singer LG; Cobos I; Humar A
J Heart Lung Transplant; 2008 Jan; 27(1):11-6. PubMed ID: 18187081
[TBL] [Abstract][Full Text] [Related]
38. Incidence of herpes zoster amongst adults varies by severity of immunosuppression.
Schröder C; Enders D; Schink T; Riedel O
J Infect; 2017 Sep; 75(3):207-215. PubMed ID: 28676411
[TBL] [Abstract][Full Text] [Related]
39. Vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia.
Betts RF
J Am Acad Dermatol; 2007 Dec; 57(6 Suppl):S143-7. PubMed ID: 18021866
[TBL] [Abstract][Full Text] [Related]
40. Low willingness to vaccinate against herpes zoster in a Chinese metropolis.
Lu X; Lu J; Zhang F; Wagner AL; Zhang L; Mei K; Guan B; Lu Y
Hum Vaccin Immunother; 2021 Nov; 17(11):4163-4170. PubMed ID: 34370590
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
